Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Cervical Cancer, May 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 329 articles:
HTML format


 

Single Articles

  1. AHMADLOO N, Heidarpourfard M, Najib FS, Shiravani Z, et al
    The Feasibility and Safety of Induction Chemotherapy Followed by Definitive Chemoradiation in Patients with Locally Advanced Cervical Cancer: A Single-Arm Phase II Clinical Trial.
    Asian Pac J Cancer Prev. 2023;24:1321-1330.
    PubMed    
    Abstract available

  2. ROH S, Lee HY, Jun JS, Lee YS, et al
    Andersen's Behavioral Model to Identify Correlates of Cervical Cancer Knowledge among American Indian Women.
    Asian Pac J Cancer Prev. 2023;24:1151-1157.
    PubMed    
    Abstract available

  3. LI XY, Wen JY, Huang YH, Wang WW, et al
    Primary Treatment for Clinically Early Cervical Cancer with Lymph Node Metastasis: Radical Surgery or Radiation?
    Curr Med Sci. 2023 Apr 28. doi: 10.1007/s11596-023-2722.
    PubMed    
    Abstract available

  4. ISLA-ORTIZ D, Torres-Dominguez J, Perez-Peralta L, Jimenez-Barrera H, et al
    Insurance status and access to cervical cancer treatment in a specialized cancer center in Mexico.
    Medicine (Baltimore). 2023;102:e33655.
    PubMed    
    Abstract available

  5. YEON CHOI H, Park JW
    Survival outcomes of minimally invasive versus open radical hysterectomy in patients with early-stage IB1 to IIA2 cervical cancer: A single-center retrospective study.
    Medicine (Baltimore). 2023;102:e33702.
    PubMed    
    Abstract available

  6. ZANG Y, Zhao R, Wang T, Gao Y, et al
    Identification of POLQ as a key gene in cervical cancer progression using integrated bioinformatics analysis and experimental validation.
    Mol Med Rep. 2023;27:115.
    PubMed    
    Abstract available

  7. ISLAM MR, Dhar PS, Akash S, Sharma R, et al
    Public concerns about cervical cancer: outbreak, types, risk factors, etiology, stages, symptoms, prevention, and treatment.
    Ann Med Surg (Lond). 2023;85:1334-1335.
    PubMed    


  8. TEKA B, Yoshida-Court K, Firdawoke E, Chanyalew Z, et al
    Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian Women.
    Microorganisms. 2023;11:833.
    PubMed    
    Abstract available

  9. STUOPELYTE R, Zukiene G, Breiviene R, Rudaitis V, et al
    Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy.
    Medicina (Kaunas). 2023;59:777.
    PubMed    
    Abstract available

  10. DIMITROVA P, Vasileva-Slaveva M, Shivarov V, Hasan I, et al
    Infiltration by Intratumor and Stromal CD8 and CD68 in Cervical Cancer.
    Medicina (Kaunas). 2023;59:728.
    PubMed    
    Abstract available

  11. CIANCI S, Tarascio M, Arcieri M, La Verde M, et al
    Post Treatment Sexual Function and Quality of Life of Patients Affected by Cervical Cancer: A Systematic Review.
    Medicina (Kaunas). 2023;59:704.
    PubMed    
    Abstract available

  12. KORBECKI J, Bosiacki M, Barczak K, Lagocka R, et al
    Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer.
    Int J Mol Sci. 2023;24:7262.
    PubMed    
    Abstract available

  13. SEKARAN K, Varghese RP, Gopikrishnan M, Alsamman AM, et al
    Unraveling the Dysbiosis of Vaginal Microbiome to Understand Cervical Cancer Disease Etiology-An Explainable AI Approach.
    Genes (Basel). 2023;14:936.
    PubMed    
    Abstract available

  14. XIANG S, Wei M, Zhao L, Lin A, et al
    Integrated Analyses of the Expression and Prognostic Value of EPHB6 in Cervical Cancer and Its Correlation with Immune Infiltrates.
    J Oncol. 2023;2023:2258906.
    PubMed    
    Abstract available

  15. CHAUHAN NK, Singh K, Kumar A, Kolambakar SB, et al
    HDFCN: A Robust Hybrid Deep Network Based on Feature Concatenation for Cervical Cancer Diagnosis on WSI Pap Smear Slides.
    Biomed Res Int. 2023;2023:4214817.
    PubMed    
    Abstract available

  16. LIU M, Lu J, Zhi Y, Ruan Y, et al
    Microendoscopy in vivo for the pathological diagnosis of cervical precancerous lesions and early cervical cancer.
    Infect Agent Cancer. 2023;18:26.
    PubMed    
    Abstract available

  17. JHA AK, Mithun S, Sherkhane UB, Jaiswar V, et al
    Systematic review and meta-analysis of prediction models used in cervical cancer.
    Artif Intell Med. 2023;139:102549.
    PubMed    
    Abstract available

  18. XIN X, Jia-Yin Y, Jun-Yang H, Rui W, et al
    Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis.
    Comput Biol Med. 2023;159:106943.
    PubMed    
    Abstract available

  19. DADIPOOR S, Alavi A, Kader Z, Kakhaki HES, et al
    Correction: Utilization of cervical cancer screening services and its associated factors in Iran: a case-control study.
    Infect Agent Cancer. 2023;18:25.
    PubMed    


  20. KIM W, Chun S, Lee SA
    Changes in cervical dysplasia, carcinoma in situ, and cervical cancer after expanding the National Cancer Screening Program to younger women in Korea.
    Int J Qual Health Care. 2023 Apr 25:mzad024. doi: 10.1093.
    PubMed    
    Abstract available

  21. MIYASAKA Y, Yoshimoto Y, Ando K, Murata K, et al
    CD8-positive Tumor-infiltrating Lymphocytes and Prognosis in Radiotherapy for Uterine Cervical Squamous Cell Carcinoma.
    Anticancer Res. 2023;43:2077-2084.
    PubMed    
    Abstract available

  22. FIRTINA TUNCER S, Tuncer HA
    Cervical Cancer Screening in Women Aged Older Than 65 Years.
    J Low Genit Tract Dis. 2023 Apr 25. doi: 10.1097/LGT.0000000000000742.
    PubMed    
    Abstract available

  23. HAN D, Wang J, Cheng G
    Retraction: LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis.
    Oncotarget. 2023;14:363.
    PubMed    


  24. JENSEN B, Khan H, Layeequr Rahman R
    Sociodemographic Determinants in Cervical Cancer Screening Among the Underserved West Texas Women.
    Womens Health Rep (New Rochelle). 2023;4:191-201.
    PubMed    
    Abstract available

  25. XIA WT, Qiu WR, Yu WK, Xu ZC, et al
    Identifying TME signatures for cervical cancer prognosis based on GEO and TCGA databases.
    Heliyon. 2023;9:e15096.
    PubMed    
    Abstract available

  26. RANGA S, Yadav R, Chhabra R, Chauhan MB, et al
    Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives.
    Apoptosis. 2023 Apr 25:1-18. doi: 10.1007/s10495-023-01840.
    PubMed    
    Abstract available

  27. CHEN Y, Ma Q, Sun N
    DDX49 Promotes Proliferation and Metastasis of Cervical Cancer by Regulation of AKT and Wnt/beta-Catenin Signalings.
    Ann Clin Lab Sci. 2023;53:271-277.
    PubMed    
    Abstract available

  28. SONG G, Ren J, Li Y, Cui J, et al
    Interference with XPO1 Suppresses the Stemness and Radioresistance of CD44 Positive Cervical Cancer Cells via Binding with Rad21.
    Ann Clin Lab Sci. 2023;53:278-292.
    PubMed    
    Abstract available

  29. RUCKRIEGL S, Loris J, Wert K, Bauerschmitz G, et al
    Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells.
    Cancer Genomics Proteomics. 2023;20:281-297.
    PubMed    
    Abstract available

  30. GOMES D, Passarinha LA, Sousa A
    E6 Tagged Protein Production, Extraction, and Purification from Escherichia coli Lysate.
    Methods Mol Biol. 2023;2652:21-33.
    PubMed    
    Abstract available

  31. ADDLEY S, Persic M, Kirke R, Abdul S, et al
    Combined direct hysteroscopic and real-time ultrasound guidance facilitating safe insertion of intra-uterine brachytherapy applicator for locally advanced cervical cancer with significant endocervical stenosis: A novel collaborative approach.
    Gynecol Oncol Rep. 2023;47:101178.
    PubMed    
    Abstract available

  32. DEY T, Mukerjee A, Rai B, Arora M, et al
    Early integration of palliative care in cervical cancer: Experiences from a pilot study.
    J Family Med Prim Care. 2023;12:366-370.
    PubMed    
    Abstract available

  33. ENDALAMAW A, Alganeh H, Azage M, Atnafu A, et al
    Improving cervical cancer continuum of care towards elimination in Ethiopia: a scoping review.
    Res Sq. 2023 Apr 14:rs.3.rs-2791526. doi: 10.21203/rs.3.rs-2791526.
    PubMed    
    Abstract available

  34. SHITU BF, Atnafu DD, Agumas Y
    Public School Adolescents Had Increased Odds of Being Willing to Uptake HPV Vaccinations Owing to Sociodemographic and Healthcare Access Features in Bahir Dar City, Ethiopia.
    Biomed Res Int. 2023;2023:2663815.
    PubMed    
    Abstract available


  35. [Synthesis of evidence and recommendations: guidelines for cervical cancer screening, detection, and treatmentSintese de evidencias e recomendacoes: diretrizes para rastreamento, deteccao e tratamento do cancer do colo do utero].
    Rev Panam Salud Publica. 2023;47:e72.
    PubMed    
    Abstract available

  36. ZHANG J, Chen J, Yang X, Han J, et al
    Novel risk prediction models, involving coagulation, thromboelastography, stress response, and immune function indicators, for deep vein thrombosis after radical resection of cervical cancer and ovarian cancer.
    J Obstet Gynaecol. 2023;43:2204162.
    PubMed    
    Abstract available

  37. PIETA E
    Nanoscale insight into biochemical changes in cervical cancer cells exposed to adaptogenic drug.
    Micron. 2023;170:103462.
    PubMed    
    Abstract available

  38. BOLARINWA OA, Holt N
    Barriers to breast and cervical cancer screening uptake among Black, Asian, and Minority Ethnic women in the United Kingdom: evidence from a mixed-methods systematic review.
    BMC Health Serv Res. 2023;23:390.
    PubMed    
    Abstract available

  39. GULIASHVILI G, Taboridze I, Mebonia N, Alibegashvili T, et al
    Evaluation of barriers to cervical cancer screening in Georgia.
    Cent Eur J Public Health. 2023;31:9-18.
    PubMed    
    Abstract available

  40. POLEBOYINA PK, Alagumuthu M, Pasha A, Ravinder D, et al
    Entrectinib a Plausible Inhibitor for Osteopontin (SPP1) in Cervical Cancer-Integrated Bioinformatic Approach.
    Appl Biochem Biotechnol. 2023 Apr 22. doi: 10.1007/s12010-023-04541.
    PubMed    
    Abstract available

  41. DUCHANGE N, Poiseuil M, Rollet Q, Piette C, et al
    How do women comply with cancer screenings? A study in four regions of France.
    BMC Womens Health. 2023;23:190.
    PubMed    
    Abstract available

  42. DZOBO M, Dzinamarira T, Maluleke K, Jaya ZN, et al
    Mapping evidence on the acceptability of human papillomavirus self-sampling for cervical cancer screening among women in sub-Saharan Africa: a scoping review.
    BMJ Open. 2023;13:e062090.
    PubMed    
    Abstract available

  43. MAURY P, Mondini M, Chargari C, Darricau A, et al
    Clinical transfer of AGuIX(R)-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework.
    Nanomedicine. 2023 Apr 19:102676. doi: 10.1016/j.nano.2023.102676.
    PubMed    
    Abstract available

  44. MAO P, Zhang C, Wang X, Yang H, et al
    Copious vaginal discharge finally diagnosed as cervical adenocarcinoma: A case report.
    Medicine (Baltimore). 2023;102:e33614.
    PubMed    
    Abstract available

  45. LI LP, Rao DF, Chen XX, Qi XY, et al
    The impact of hospital-family integrated continuation nursing based on information technology on patients unhealthy mood, family function and sexual function after cervical cancer surgery.
    Medicine (Baltimore). 2023;102:e33504.
    PubMed    
    Abstract available

  46. OGAWA M, Hashimoto K, Kitano S, Yamashita S, et al
    Estrogen induces genomic instability in high-risk HPV-infected cervix and promotes the carcinogenesis of cervical adenocarcinoma.
    Biochem Biophys Res Commun. 2023;659:80-90.
    PubMed    
    Abstract available

  47. QIU D, Liu Y, Wang Z, Zhang Z, et al
    Precision and correlation of ED(50) and endpoint titer method in measuring HPV vaccine immunogenicity.
    J Virol Methods. 2023;316:114716.
    PubMed    
    Abstract available

  48. MUNIR MM, Woldesenbet S, Alaimo L, Moazzam Z, et al
    Mediators of county-level racial and economic privilege in cancer screening.
    J Surg Oncol. 2023;127:1212-1222.
    PubMed    
    Abstract available

  49. EFFAH K, Agbemafle I, Essel NO, Amuah JE, et al
    Comparison of the AmpFire and MA-6000 polymerase chain reaction platforms for high-risk human papillomavirus testing in cervical precancer screening.
    J Virol Methods. 2023;316:114709.
    PubMed    
    Abstract available

  50. YU J, Kenkre J, Wallace S, Thomas S, et al
    Methodological reflections on the recruitment and engagement of people for cancer screening research in Wales.
    Aust J Prim Health. 2023;29:148-154.
    PubMed    
    Abstract available

  51. DAVIDESKO S, Meirovitz M, Shaco-Levy R, Wainstock T, et al
    Positive pathological margins after loop electrosurgical excision procedure - Management and outcome.
    Eur J Surg Oncol. 2023;49:1031-1036.
    PubMed    
    Abstract available

  52. GORDON J, Bail J
    Cancer Prevention Begins in Middle School: The Personal Advantages of HPV Immunization in Males.
    NASN Sch Nurse. 2023;38:114-120.
    PubMed    
    Abstract available

  53. BROWER JV, Bradley KA, Russo AL
    Management of Radiographically Positive Pelvic and/or Para-aortic Lymph Nodes During Primary Chemoradiation Therapy for Cervix Cancer.
    Pract Radiat Oncol. 2023;13:246-250.
    PubMed    


  54. LI Z, Winer RL, Ba S, Sy MP, et al
    Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance among Women in Senegal, West Africa.
    J Infect Dis. 2022 Oct 31. pii: 6782258. doi: 10.1093.
    PubMed    
    Abstract available


  55. Correction: The HPV16 E6, E7/miR-23b-3p/ICAT signaling axis promotes proliferation, migration, invasion and EMT of cervical cancer cells.
    Carcinogenesis. 2023 May 5:bgad022. doi: 10.1093.
    PubMed    


  56. CIBULA D, Raspollini MR, Planchamp F, Centeno C, et al
    ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
    Virchows Arch. 2023 May 5. doi: 10.1007/s00428-023-03552.
    PubMed    
    Abstract available

  57. WANG D, Zhang Y, Ren D, Meng C, et al
    Bioinformatics analysis illustrates the functions of miR-377-5p in cervical cancer.
    Biotechnol Genet Eng Rev. 2023 May 5:1-12. doi: 10.1080/02648725.2023.2208453.
    PubMed    
    Abstract available

  58. SINEQUE A, Catalao C, Ceffa S, Fonseca AM, et al
    Screening approaches for cervical cancer in Mozambique in HIV positive and negative women.
    Eur J Cancer Prev. 2023 May 3. doi: 10.1097/CEJ.0000000000000802.
    PubMed    
    Abstract available

  59. YIN Z, Hua X, Lu M
    Integrated network pharmacology and metabolomics to dissect the mechanisms of naringin for treating cervical cancer.
    Comb Chem High Throughput Screen. 2023.
    PubMed    
    Abstract available

  60. LI Q, Liu L, Gu Z, Li M, et al
    Sense of coherence mediates perceived social support and depressive and anxiety symptoms in cervical cancer patients: a cross-sectional study.
    BMC Psychiatry. 2023;23:312.
    PubMed    
    Abstract available

  61. TAO T, Zhang P, Zeng Z, Wang M, et al
    Advances in autophagy modulation of natural products in cervical cancer.
    J Ethnopharmacol. 2023 May 2:116575. doi: 10.1016/j.jep.2023.116575.
    PubMed    
    Abstract available

  62. CUI YY, Wen LY, Chen XY, Bai XH, et al
    Pelvic floor dysfunction and its influencing factors during radiotherapy in cervical cancer survivors: A cross-sectional study.
    Eur J Oncol Nurs. 2023;64:102307.
    PubMed    
    Abstract available

  63. AKOTO EJ, Allsop MJ
    Factors Influencing the Experience of Breast and Cervical Cancer Screening Among Women in Low- and Middle-Income Countries: A Systematic Review.
    JCO Glob Oncol. 2023;9:e2200359.
    PubMed    
    Abstract available

  64. LIU GF, Zhang SH, Li XF, Cao LY, et al
    Retraction: Overexpression of microRNA-132 enhances the radiosensitivity of cervical cancer cells by down-regulating Bmi-1.
    Oncotarget. 2023;14:398.
    PubMed    


  65. KINOSHITA T, Takahashi S, Anada M, Nishide T, et al
    A retrospective study of locally advanced cervical cancer cases treated with CT-based 3D-IGBT compared with 2D-IGBT.
    Jpn J Radiol. 2023 May 4. doi: 10.1007/s11604-023-01439.
    PubMed    
    Abstract available

  66. LIU G, Li L, Shang D, Zhou C, et al
    BRSK1 confers cisplatin resistance in cervical cancer cells via regulation of mitochondrial respiration.
    J Cancer Res Clin Oncol. 2023 May 4. doi: 10.1007/s00432-023-04821.
    PubMed    
    Abstract available

  67. XIE K, Liu L, Wang M, Li X, et al
    IMPA2 blocks cervical cancer cell apoptosis and induces paclitaxel resistance through p53-mediated AIFM2 regulation.
    Acta Biochim Biophys Sin (Shanghai). 2023 Apr 25. doi: 10.3724/abbs.2023069.
    PubMed    
    Abstract available

  68. TANG J, Peng H, Xu F, Luo P, et al
    Demethoxycurcumin represses cervical cancer growth through PPARgamma-regulated proliferation and apoptosis.
    Acta Biochim Biophys Sin (Shanghai). 2023 Feb 25. doi: 10.3724/abbs.2023077.
    PubMed    


  69. FILLON M
    Why young patients with cancer refuse the human papillomavirus vaccine.
    CA Cancer J Clin. 2023;73:225-227.
    PubMed    


  70. DIAZ JFR
    Cost analysis of three-dimensional radiation therapy versus intensity-modulated chemoradiotherapy for locally advanced cervical cancer in Peruvian citizens.
    Ecancermedicalscience. 2023;17:1531.
    PubMed    
    Abstract available

  71. OGUNDIPE L, Ojo T, Oluwadare T, Olayemi E, et al
    Cervical cancer screening and vaccination: knowledge, awareness, and attitude of female staff in a Nigerian University.
    BMC Womens Health. 2023;23:218.
    PubMed    
    Abstract available

  72. ZHANG Y, Ni Z, Wei T, Liu Q, et al
    Persistent HPV infection after conization of cervical intraepithelial neoplasia-- a systematic review and meta-analysis.
    BMC Womens Health. 2023;23:216.
    PubMed    
    Abstract available

  73. ZHAO M, Pu X, Ma GY, Zhang MJ, et al
    Quality of life in patients with cervical cancer between the Han nationality and ethnic minorities in the Yunnan Province of China.
    BMC Womens Health. 2023;23:217.
    PubMed    
    Abstract available

  74. ZHANG Z, Zhang N, Cheng G
    Application of three-dimensional multi-imaging combination in brachytherapy of cervical cancer.
    Radiol Med. 2023 May 3. doi: 10.1007/s11547-023-01632.
    PubMed    
    Abstract available

  75. MO Y, Liang Z, Lan L, Xiong X, et al
    Extracellular vesicles derived from cervical cancer cells carrying MCM3AP-AS1 promote angiogenesis and tumor growth in cervical cancer via the miR-93/p21 axis.
    Exp Cell Res. 2023 May 1:113621. doi: 10.1016/j.yexcr.2023.113621.
    PubMed    
    Abstract available

  76. CHEN X, Sun Z, Zhou S, Jiang W, et al
    SH3 domain-binding kinase 1 promotes proliferation and inhibits apoptosis of cervical cancer via activating the Wnt/beta-catenin and Raf/ERK1/2 signaling pathways.
    Mol Carcinog. 2023 May 3. doi: 10.1002/mc.23552.
    PubMed    
    Abstract available

  77. ARORA S, Tuffaha H
    Cost-effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India.
    Asia Pac J Clin Oncol. 2023 May 3. doi: 10.1111/ajco.13962.
    PubMed    
    Abstract available

  78. SHAO H, Li X, Wu P, Chen Z, et al
    A Cellular Senescence-Related Signature Predicts Cervical Cancer Patient Outcome and Immunotherapy Sensitivity.
    Res Sq. 2023 Apr 20:rs.3.rs-2769887. doi: 10.21203/rs.3.rs-2769887.
    PubMed    
    Abstract available

  79. QU SX, Ni YH, Qin JF, Chen XY, et al
    Experience and acceptability for HPV self-sampling among women in Jiangsu province, China: a cross-sectional survey.
    J Obstet Gynaecol. 2023;43:2204942.
    PubMed    
    Abstract available

  80. OLKOV IG, Grishina NK
    [The preferential strategies of programs of cervical virologic screening (publications review)].
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2023;31:233-241.
    PubMed    
    Abstract available

  81. POP CF, Stanciu-Pop CM, Jungels C, Chintinne M, et al
    Uterine embryonal rhabdomyosarcoma in adult women: a case report on the challenging diagnosis and treatment.
    Rom J Morphol Embryol. 2023;64:83-88.
    PubMed    
    Abstract available

  82. KROG L, Lycke KD, Christiansen AG, Hammer A, et al
    Insufficient training in colposcopy and loop electrosurgical excision procedure among residents.
    Dan Med J. 2023;70:A11220695.
    PubMed    
    Abstract available

  83. DING Y, Wu X, Yang X
    Identification of miRNAs and target genes associated with lymph node metastasis in cervical cancer using bioinformatics analysis.
    Toxicol Mech Methods. 2023 Apr 26:1-27. doi: 10.1080/15376516.2023.2207644.
    PubMed    
    Abstract available

  84. VALSAN A, Meenu MT, Murali VP, Malgija B, et al
    Exploration of Phaeanthine: A Bisbenzylisoquinoline Alkaloid Induces Anticancer Effect in Cervical Cancer Cells Involving Mitochondria-Mediated Apoptosis.
    ACS Omega. 2023;8:14799-14813.
    PubMed    
    Abstract available

  85. WAHEED DE, Bolio A, Guillaume D, Sidibe A, et al
    Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource countries?
    Front Public Health. 2023;11:1112981.
    PubMed    
    Abstract available

  86. CHEN X, Lin L, Wu Q, Li S, et al
    Tumor Necrosis Factor-alpha Promotes the Tumorigenesis, Lymphangiogenesis, and Lymphatic Metastasis in Cervical Cancer via Activating VEGFC-Mediated AKT and ERK Pathways.
    Mediators Inflamm. 2023;2023:5679966.
    PubMed    
    Abstract available

  87. WANG L, Liu P, Duan H, Li P, et al
    Abdominal type B vs. type C radical hysterectomy in early-stage cervical cancer: A matched single center cohort report.
    Front Surg. 2023;10:1166084.
    PubMed    
    Abstract available

  88. LEATH CA 3RD, Nysenbaum J, Ting J, Zhang YJ, et al
    Patterns of care and health care resource use among Medicaid-enrolled women with recurrent or metastatic cervical cancer.
    J Manag Care Spec Pharm. 2023;29:490-498.
    PubMed    
    Abstract available

  89. O'LAUGHLIN DJ, Strelow BA, Fellows NA, Stevens JN, et al
    Papanicolaou test collection with the Papette brush or the spatula with cytobrush: A pragmatic study.
    Womens Health (Lond). 2023;19:17455057231170975.
    PubMed    
    Abstract available

  90. SHERO AA, Kaso AW, Tafa M, Agero G, et al
    Cervical cancer screening utilization and associated factors among women attending antenatal care at Asella Referral and Teaching Hospital, Arsi zone, South Central Ethiopia.
    BMC Womens Health. 2023;23:199.
    PubMed    
    Abstract available

  91. MENDULO R, Chiumia IK
    The state of cervical cancer screening in imprisoned women in Malawi: a case of Maula Prison.
    BMC Womens Health. 2023;23:198.
    PubMed    
    Abstract available

  92. NANG DW, Tukirinawe H, Okello M, Tayebwa B, et al
    Prevalence of high-risk human papillomavirus infection and associated factors among women of reproductive age attending a rural teaching hospital in western Uganda.
    BMC Womens Health. 2023;23:209.
    PubMed    
    Abstract available

  93. WANG C, Liu L, Cheng Y, Shi H, et al
    Combined GSK-3beta and MEK inhibitors modulate the stemness and radiotherapy sensitivity of cervical cancer stem cells through the Wnt signaling pathway.
    Chem Biol Interact. 2023 Apr 26:110515. doi: 10.1016/j.cbi.2023.110515.
    PubMed    
    Abstract available

  94. DEVI S, Gaikwad SR, R H
    Prediction and Detection of Cervical Malignancy Using Machine Learning Models.
    Asian Pac J Cancer Prev. 2023;24:1419-1433.
    PubMed    
    Abstract available

  95. OTHMAN AA, Goreal AA, Pity IS
    Genotyping and Phylogenetic Analysis of Human Papillomaviruses in Formalin Fixed Paraffin Embedded Sections from Cervical Lesions in Duhok-Iraq.
    Asian Pac J Cancer Prev. 2023;24:1313-1319.
    PubMed    
    Abstract available

  96. UWAMUNGU S, Nigussie B, Muvunyi CM, Hasseus B, et al
    Prevalence of Human Papillomavirus in Different Mucous Membranes in HIV Concordant Couples in Rwanda.
    Viruses. 2023;15:1005.
    PubMed    
    Abstract available

  97. NICOLO S, Antonelli A, Tanturli M, Baccani I, et al
    Bacterial Species from Vaginal Microbiota Differently Affect the Production of the E6 and E7 Oncoproteins and of p53 and p-Rb Oncosuppressors in HPV16-Infected Cells.
    Int J Mol Sci. 2023;24:7173.
    PubMed    
    Abstract available

  98. OVESTAD IT, Dalen I, Andersland MS, Vintermyr OK, et al
    Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program-A Prospective Observational Study from Western Norway.
    Int J Mol Sci. 2023;24:7158.
    PubMed    
    Abstract available

  99. PLOTZKER RE, Vaidya A, Pokharel U, Stier EA, et al
    Sexually Transmitted Human Papillomavirus: Update in Epidemiology, Prevention, and Management.
    Infect Dis Clin North Am. 2023;37:289-310.
    PubMed    
    Abstract available

  100. CHO H, Park S, Kim HS
    Gastric-type Endocervical Adenocarcinoma: Comprehensive Cytopathological Analysis and Comparison With Usual-type Endocervical Adenocarcinoma.
    In Vivo. 2023;37:1173-1181.
    PubMed    
    Abstract available

  101. TOLCHER A, Hamilton E, Coleman RL
    The evolving landscape of antibody-drug conjugates in gynecologic cancers.
    Cancer Treat Rev. 2023;116:102546.
    PubMed    
    Abstract available

  102. MARUYAMA S, Sakabe N, Ito C, Shimoyama Y, et al
    Effect of Specimen Processing Technique on Cell Detection and Classification by Artificial Intelligence.
    Am J Clin Pathol. 2023;159:448-454.
    PubMed    
    Abstract available

  103. TOLOSKO JA, Beauchesne M, Rancatore E
    Knowledge, attitudes, and practice of the Pap smear test in female college students attending a global university in the United States.
    J Am Assoc Nurse Pract. 2023;35:322-329.
    PubMed    
    Abstract available

  104. MERGUI JL, Gondry J, Hocquemiller R, Carcopino X, et al
    [Revision of the French colposcopic terminology].
    Gynecol Obstet Fertil Senol. 2023;51:239-248.
    PubMed    
    Abstract available

  105. WATANABE Y, Ueda Y, Yagi A, Ikeda S, et al
    Disparities among Japanese municipalities in recommendations for routine and catch-up HPV vaccinations.
    Cancer Sci. 2023;114:2139-2144.
    PubMed    
    Abstract available

  106. CARETTO M, Giannini A, Simoncini T
    The impact of the pandemic on gynecological oncology practice: Three years later.
    Maturitas. 2023;172:69-70.
    PubMed    


  107. MCCLYMONT E, Tan DH, Bondy S, Albert A, et al
    HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV.
    Int J STD AIDS. 2023 Jan 26:9564624231154298. doi: 10.1177/09564624231154298.
    PubMed    
    Abstract available

  108. KUSAKABE M, Taguchi A, Tanikawa M, Hoshi D, et al
    Application of organoid culture from HPV18-positive small cell carcinoma of the uterine cervix for precision medicine.
    Cancer Med. 2023;12:8476-8489.
    PubMed    
    Abstract available

  109. CHEN X, Pu X, Chen Z, Li L, et al
    Application of EfficientNet-B0 and GRU-based deep learning on classifying the colposcopy diagnosis of precancerous cervical lesions.
    Cancer Med. 2023;12:8690-8699.
    PubMed    
    Abstract available

  110. LI Y, Cao L, Han X, Ma Y, et al
    Altered vaginal eukaryotic virome is associated with different cervical disease status.
    Virol Sin. 2023;38:184-197.
    PubMed    
    Abstract available

  111. KIRKEGAARD P, Larsen MB, Andersen B
    "It's cancer screening after all". Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening.
    J Med Screen. 2023;30:74-80.
    PubMed    
    Abstract available

  112. WANG J, Xi M, Bian C, Yang L, et al
    Mixed spindle and squamous cell carcinoma of the uterine cervix: A case report.
    Asian J Surg. 2023;46:2237-2238.
    PubMed    


  113. KOTAKA S, Kondo E, Kawai Y, Okamoto K, et al
    Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer.
    J Gynecol Oncol. 2023 Apr 28. doi: 10.3802/jgo.2023.
    PubMed    
    Abstract available

  114. XU WY, Raver E, Jung J, Li Y, et al
    Rural-urban disparities in preventive breast and cervical cancer screening among women with early-onset dementia.
    BMC Womens Health. 2023;23:255.
    PubMed    
    Abstract available

  115. PAK T, Sadowski EA, Patel-Lippmann K
    MR Imaging in Cervical Cancer: Initial Staging and Treatment.
    Radiol Clin North Am. 2023;61:639-649.
    PubMed    
    Abstract available

  116. HOANG BX, Han BO, Tran HQ, Fang WH, et al
    Successful Phytotherapy for Acute Refractory Radiation Cystitis in a Cervical Cancer Patient: A Case Report.
    Cancer Diagn Progn. 2023;3:383-386.
    PubMed    
    Abstract available

  117. STVERAKOVA T, Baranova I, Mikyskova P, Gajdosova B, et al
    Selection of endogenous control and identification of significant microRNA deregulations in cervical cancer.
    Front Oncol. 2023;13:1143691.
    PubMed    
    Abstract available

  118. MITTAL A, Neibart SS, Kulkarni A, Anderson T, et al
    Barriers and facilitators to effective cervical cancer screening in Belize: a qualitative analysis.
    Cancer Causes Control. 2023 May 11. doi: 10.1007/s10552-023-01703.
    PubMed    
    Abstract available

  119. ZHANG Q, Song J, Cao L, Sun M, et al
    RNF113A targeted by miR-197 promotes proliferation and inhibits autophagy via CXCR4/CXCL12/AKT/ERK/Beclin1 axis in cervical cancer.
    Exp Cell Res. 2023 May 8:113632. doi: 10.1016/j.yexcr.2023.113632.
    PubMed    
    Abstract available

  120. SOLANKI R, Jangid AK, Jadav M, Kulhari H, et al
    Folate Functionalized and Evodiamine-Loaded Pluronic Nanomicelles for Augmented Cervical Cancer Cell Killing.
    Macromol Biosci. 2023 May 10:e2300077. doi: 10.1002/mabi.202300077.
    PubMed    
    Abstract available

  121. MARKOWITZ LE, Unger ER
    Human Papillomavirus Vaccination.
    N Engl J Med. 2023;388:1790-1798.
    PubMed    


  122. JIN Y, Xie S, Sheng B, Chen M, et al
    The effect of propofol on chemosensitivity of paclitaxel in cervical cancer cells.
    Cancer Med. 2023 May 10. doi: 10.1002/cam4.6064.
    PubMed    
    Abstract available

  123. WEI B, Li Q, Seery S, Qiao Y, et al
    Endocervical curettage for diagnosing high-grade squamous intraepithelial lesions or worse in women with type 3 transformation zone lesions: a retrospective, observational study.
    BMC Womens Health. 2023;23:245.
    PubMed    
    Abstract available

  124. MIJITI Y, Yusupu H, Liu H, Zhang X, et al
    Survey on cervical cancer knowledge and its influencing factors among 2,578 women in Shache county, Kashi, China.
    BMC Womens Health. 2023;23:246.
    PubMed    
    Abstract available

  125. MERKURI L, Kamberi F, Qorri E, Shapo L, et al
    Assessment of the Albanian University female students' knowledge, attitudes, and practices on cervical cancer.
    J Infect Dev Ctries. 2023;17:534-541.
    PubMed    
    Abstract available

  126. ZHAO Y, Ma Y, Zang A, Cheng Y, et al
    First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors.
    J Hematol Oncol. 2023;16:50.
    PubMed    
    Abstract available

  127. ZHAO X, Zhang R, Song Z, Yang K, et al
    Curcumin suppressed the proliferation and apoptosis of HPV-positive cervical cancer cells by directly targeting the E6 protein.
    Phytother Res. 2023 May 8. doi: 10.1002/ptr.7868.
    PubMed    
    Abstract available

  128. YANG G, He Y, Chen Y, Huang Z, et al
    Antitumor activity of galaxamide involved in cell apoptosis and stemness by inhibiting Wnt/beta-catenin pathway in cervical cancer.
    Drug Dev Res. 2023 May 8. doi: 10.1002/ddr.22073.
    PubMed    
    Abstract available

  129. HAN X, Du S, Chen X, Min X, et al
    Lactate-mediated Fascin protrusions promote cell adhesion and migration in cervical cancer.
    Theranostics. 2023;13:2368-2383.
    PubMed    
    Abstract available

  130. AN J, Li X, Wang J, Zhu L, et al
    Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1-positive advanced cervical cancer: a phase II, single-arm study.
    Front Immunol. 2023;14:1142256.
    PubMed    
    Abstract available

  131. DENG B, Li A, Zhu Y, Zhou Y, et al
    SHCBP1 contributes to the proliferation and self‑renewal of cervical cancer cells and activation of the NF‑kappaB signaling pathway through EIF5A.
    Oncol Lett. 2023;25:246.
    PubMed    
    Abstract available

  132. SHASWATI M, Oeishy FH, Mumu SB, Zahid MZI, et al
    Polymorphisms of the interleukin-6 (IL-6) gene contribute to cervical cancer susceptibility in Bangladeshi women: A case-control study.
    Health Sci Rep. 2023;6:e1238.
    PubMed    
    Abstract available

  133. AKBARI A, Khayamzadeh M, Salmanian R, Moradi A, et al
    Epidemiology and survival of cervical cancer in Iran based on national cancer registry data (2008-2014).
    Front Oncol. 2023;13:1132369.
    PubMed    
    Abstract available

  134. YANG X, Zhang W, Zhu W
    Profiling of immune responses by lactate modulation in cervical cancer reveals key features driving clinical outcome.
    Heliyon. 2023;9:e14896.
    PubMed    
    Abstract available

  135. YANG X, Li Z, Zhang L, Li H, et al
    The effect of radiotherapy time and dose on acute hematologic toxicity during concurrent postoperative chemoradiotherapy for early high-risk cervical cancer.
    J Cancer. 2023;14:895-902.
    PubMed    
    Abstract available

  136. MENG Q, Liu X, Hu K, Hou X, et al
    Image-guided intensity-modulated radiotherapy in patients with FIGO IIIC1 cervical cancer: efficacy, toxicity and prognosis.
    J Cancer. 2023;14:1001-1010.
    PubMed    
    Abstract available

  137. CHAYO I, Uribe Perez CJ, De Vries E, Pinheiro PS, et al
    The impact of health insurance affiliation and socioeconomic status on cervical cancer survival in Bucaramanga, Colombia.
    Cancer Epidemiol. 2023;85:102375.
    PubMed    
    Abstract available

  138. PETRIE K, Wells A, Eckert LO
    Human Papillomavirus Vaccine: The Cancer Prevention Moonshot.
    Obstet Gynecol Clin North Am. 2023;50:339-348.
    PubMed    
    Abstract available

  139. MEHDI HK, Raju K, Sheela SR
    Association of P16, Ki-67, and CD44 expression in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of the cervix.
    J Cancer Res Ther. 2023;19.
    PubMed    
    Abstract available

  140. SINGH B, Singh G, Oinam AS, Kumar V, et al
    Radiobiological modeling of radiation-induced acute rectal mucositis: A single-institutional study of cervical carcinoma.
    J Cancer Res Ther. 2023;19.
    PubMed    
    Abstract available

  141. CHUGHTAI N, Perveen K, Gillani SR, Abbas A, et al
    National cervical cancer burden estimation through systematic review and analysis of publicly available data in Pakistan.
    BMC Public Health. 2023;23:834.
    PubMed    
    Abstract available

  142. XU X, Wang X, Chen Q, Zheng A, et al
    Sp1 promotes tumour progression by remodelling the mitochondrial network in cervical cancer.
    J Transl Med. 2023;21:307.
    PubMed    
    Abstract available

  143. SPENCER JC, Kim JJ, Tiro JA, Feldman S, et al
    Racial and Ethnic Disparities in Cervical Cancer Screening from Three US Healthcare Settings.
    Am J Prev Med. 2023 May 3:S0749-3797(23)00202.
    PubMed    
    Abstract available

  144. KARAFEZIEVA BV, Prandzhev GD, Mateva S, Totev T, et al
    Robot-Assisted Hysterectomy for Primary Choriocarcinoma of the Cervix - A Novel Approach.
    Chirurgia (Bucur). 2023;118:202-207.
    PubMed    
    Abstract available

  145. METE B, Utuk FA, Demirhindi H, Inaltekin A, et al
    Human papillomavirus vaccine administration among women in the Eastern Mediterranean region of Turkey: prevalence and barriers.
    Eur Rev Med Pharmacol Sci. 2023;27:3526-3533.
    PubMed    
    Abstract available

  146. MACHIDA M, Inoue S
    Patterns of HPV vaccine hesitancy among catch-up generations in Japan: A descriptive study.
    Vaccine. 2023 Apr 4:S0264-410X(23)00355-9. doi: 10.1016/j.vaccine.2023.
    PubMed    
    Abstract available

  147. MA Y, Li Y, Liu Y, Cao L, et al
    Vaginal Microbiome Dysbiosis is Associated with the Different Cervical Disease Status.
    J Microbiol. 2023;61:423-432.
    PubMed    
    Abstract available

  148. SETIAWAN D, Annisa AN, Lianawati, Hutubessy RCW, et al
    The Cost Analysis of Human Papillomavirus Vaccination Program in Indonesia.
    Value Health Reg Issues. 2023;35:102-108.
    PubMed    
    Abstract available

  149. RUEL-LALIBERTE J, Jacob-Wagner M, Bestman-Smith J, Pare J, et al
    Acceptability and Preferences of Dry HR HPV Self-Sampling Mailed Kits Among Canadian Women: A Cross-Sectional Study.
    J Obstet Gynaecol Can. 2023;45:261-266.
    PubMed    
    Abstract available

  150. RICKFORD R, Rogers M, Halliday A, Lamptey P, et al
    Attitudes to reducing cervical screening frequency among UK women: A qualitative analysis.
    Psychooncology. 2023;32:721-729.
    PubMed    
    Abstract available

  151. RADU CA, Matos de Melo Fernandes N, Khalfe S, Stordal B, et al
    Awareness of ovarian cancer symptoms and risk factors in a young ethnically diverse British population.
    Cancer Med. 2023;12:9879-9892.
    PubMed    
    Abstract available

  152. AVILA S, Ruiz MJ, Petereit D, Arya R, et al
    Communicating the Gynecologic Brachytherapy Experience (CoGBE): Clinician perceived benefits of a graphic narrative discussion guide.
    Brachytherapy. 2023;22:352-360.
    PubMed    
    Abstract available

  153. STOLNICU S, Brito MJ, Karpathiou G, Hoang L, et al
    Villoglandular Pattern in HPV-associated Endocervical Adenocarcinoma is Associated With Excellent Prognosis: A Reappraisal of 31 Cases Using IECC and Silva Pattern Classification.
    Int J Gynecol Pathol. 2023;42:270-277.
    PubMed    
    Abstract available

  154. STOLNICU S, Hoang L, Zhou Q, Iasonos A, et al
    Cervical Adenosquamous Carcinoma: Detailed Analysis of Morphology, Immunohistochemical Profile, and Outcome in 59 Cases.
    Int J Gynecol Pathol. 2023;42:259-269.
    PubMed    
    Abstract available

  155. HUANG J, Zhao Y
    E2F Transcription Factor 1 Activates FKBP Prolyl Isomerase 4 to Promote Angiogenesis in Cervical Squamous Cell Carcinoma Via the PI3K/AKT Signaling Pathway.
    Reprod Sci. 2023;30:1229-1240.
    PubMed    
    Abstract available

  156. THIEL DE BOCANEGRA H, Goliaei Z, Khan N, Banna S, et al
    Refugee Women's Receptiveness for Virtual Engagement on Reproductive Health During the COVID-19 Pandemic.
    Int J Behav Med. 2023;30:366-375.
    PubMed    
    Abstract available

  157. UMEZAWA R, Tokunaga H, Yamamoto T, Shigeta S, et al
    Retrospective analysis of local recurrence pattern by computed tomography image-guided intracavitary and interstitial brachytherapy for locally advanced cervical cancer in a single Japanese institution.
    Brachytherapy. 2023 May 18:S1538-4721(23)00052.
    PubMed    
    Abstract available

  158. FRAM R, Fram KM, Saleh S, Muhidat N, et al
    Cervical cancer screening in Jordan; a review of the past and an outlook to the future - facts and figures.
    Prz Menopauzalny. 2023;22:24-29.
    PubMed    
    Abstract available

  159. CAO H, Yan H, Bai S, Gu B, et al
    Radiation-induced lymphopenia and the survival of women with cervical cancer: a meta-analysis.
    J Obstet Gynaecol. 2023;43:2194991.
    PubMed    
    Abstract available

  160. SPEES LP, Biddell CB, Smith JS, Des Marais AC, et al
    Cost-effectiveness of human papillomavirus (HPV) self-collection intervention on cervical cancer screening uptake among underscreened US persons with a cervix.
    Cancer Epidemiol Biomarkers Prev. 2023 May 19:EPI-22-1267.
    PubMed    
    Abstract available

  161. OLWAL CO, Fabius JM, Zuliani-Alvarez L, Eckhardt M, et al
    Network modeling suggests HIV infection phenocopies PI3K-AKT pathway mutations to enhance HPV-associated cervical cancer.
    Mol Omics. 2023 May 19. doi: 10.1039/d3mo00025.
    PubMed    
    Abstract available

  162. PERKINS R, Mitchell E
    Cervical cancer disparities.
    J Natl Med Assoc. 2023;115.
    PubMed    


  163. VOGELSANG TLR, Kast V, Bagnjuk K, Eubler K, et al
    RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation in vitro.
    Front Oncol. 2023;13:1110939.
    PubMed    
    Abstract available

  164. LIU X, Song J, Liu H, Sun Z, et al
    Endoplasmic Reticulum Stress Could Predict the Prognosis of Cervical Cancer and Regulate the Occurrence of Radiation Mucositis.
    Dose Response. 2023;21:15593258231173199.
    PubMed    
    Abstract available

  165. ALKHALDI RO, Alzahrani HA, Metwally LA
    Awareness Level About Cervical Cancer, Human Papillomavirus (HPV) and Corresponding Vaccine Among Women Living in the Western Region of Saudi Arabia.
    Cureus. 2023;15:e37512.
    PubMed    
    Abstract available

  166. ZHANG X, Chen W, Zhu X, Bi H, et al
    Multiple Center Research on Relationship Between Screening Quality and Detection of Cervical Cancer - Six Provinces, China, June-December 2021.
    China CDC Wkly. 2023;5:301-305.
    PubMed    
    Abstract available

  167. ZHANG J, Liu X
    MRI is more valuable than CT in the diagnosis of cervical cancer.
    Am J Transl Res. 2023;15:2970-2976.
    PubMed    
    Abstract available

  168. SPEER L
    Majority of Grade 2 Cervical Intraepithelial Neoplasia Lesions Regress in Women 25 to 30 Years of Age.
    Am Fam Physician. 2023;107:Online.
    PubMed    


  169. ZHOU KN, Wang Y, Xie Y, Yang SH, et al
    Symptom burden survey and symptom clusters in patients with cervical cancer: a cross-sectional survey.
    Support Care Cancer. 2023;31:338.
    PubMed    
    Abstract available

  170. LUCAS E, Murillo R, Arrossi S, Barcena M, et al
    Quantification of impact of COVID-19 pandemic on cancer screening programmes - a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand.
    Elife. 2023;12:e86527.
    PubMed    
    Abstract available

  171. NIE G, Tang B, Lv M, Li D, et al
    HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition.
    Cell Biol Int. 2023 May 16. doi: 10.1002/cbin.12020.
    PubMed    
    Abstract available

  172. CERTELLI C, Anchora LP, Gallotta V
    Special Issue: "Management of Early Stage Cervical Cancer".
    Cancers (Basel). 2023;15:2343.
    PubMed    
    Abstract available

  173. PSILOPATIS I, Garmpis N, Garmpi A, Vrettou K, et al
    The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy.
    Cancers (Basel). 2023;15:2222.
    PubMed    
    Abstract available

  174. APPIDI T, Vakada M, Buddhiraju HS, Chinchulkar SA, et al
    Development of a Point-of-Care Cervico-Vaginal Sampling/Testing Device for the Colorimetric Detection of Cervical Cancer.
    Diagnostics (Basel). 2023;13:1382.
    PubMed    
    Abstract available

  175. ZHANG CN, Liu XY, Li Q, Song YZ, et al
    [Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].
    Zhonghua Zhong Liu Za Zhi. 2023;45:402-409.
    PubMed    
    Abstract available

  176. LI L, Wang LL, Zhou JY
    [Correlation and clinical significance of VISTA expression and cervical squamous cell carcinoma].
    Zhonghua Zhong Liu Za Zhi. 2023;45:396-401.
    PubMed    
    Abstract available

  177. TIAN T, Hua Z, Kong Y, Wang LZ, et al
    [The mechanism of S100A7 inducing the migration and invasion in cervical cancer cells].
    Zhonghua Zhong Liu Za Zhi. 2023;45:375-381.
    PubMed    
    Abstract available

  178. GELASSA FR, Nagari SL, Jebena DE, Belgafo D, et al
    Knowledge and practice of cervical cancer screening and its associated factors among women attending maternal health services at public health institutions in Assosa Zone, Benishangul-Gumuz, Northwest Ethiopia, 2022: a cross-sectional study.
    BMJ Open. 2023;13:e068860.
    PubMed    
    Abstract available

  179. LEE NR, Chang WH, Wang PH
    How big the excision for high-grade intraepithelial neoplasms of the cervix should be done?
    Taiwan J Obstet Gynecol. 2023;62:391-392.
    PubMed    


  180. CHUNG SY, Chang JS, Kim YB
    Comprehensive clinical evaluation of deep learning-based auto-segmentation for radiotherapy in patients with cervical cancer.
    Front Oncol. 2023;13:1119008.
    PubMed    
    Abstract available

  181. HAN S, Wang S, Lv X, Li D, et al
    Ferroptosis-related genes in cervical cancer as biomarkers for predicting the prognosis of gynecological tumors.
    Front Mol Biosci. 2023;10:1188027.
    PubMed    
    Abstract available

  182. LI G, Lamsisi M, Chenafi S, Moniod L, et al
    Urine-based detection of HPV for cervical cancer screening: Time for standardized tests.
    J Med Virol. 2023;95:e28737.
    PubMed    
    Abstract available

  183. RAMSHANKAR V, Ravindran S, Arun K, Albert K, et al
    Impact of HPV molecular testing with partial genotyping as a feasibility study in cervical cancer community screening program in South India.
    J Med Virol. 2023;95:e28715.
    PubMed    
    Abstract available

  184. LAAN JJ, van Lonkhuijzen LRCW, Stokking JA, Barten DLJ, et al
    The Effect of Contemporary Brachytherapy Practices on Prognosis in Women with Locally Advanced Cervical Cancer.
    Curr Oncol. 2023;30:4275-4288.
    PubMed    
    Abstract available

  185. ZAMMIT C, Creagh N, Nightingale C, McDermott T, et al
    'I'm a bit of a champion for it actually': qualitative insights into practitioner-supported self-collection cervical screening among early adopting Victorian practitioners in Australia.
    Prim Health Care Res Dev. 2023;24:e31.
    PubMed    
    Abstract available

  186. ZHOU G, Koroukian SM, Navale SM, Schiltz NK, et al
    Cancer burden in women with HIV on Medicaid: A nationwide analysis.
    Womens Health (Lond). 2023;19:17455057231170061.
    PubMed    
    Abstract available

  187. BABI A, Issa T, Issanov A, Akhanova S, et al
    Knowledge and attitudes of mothers toward HPV vaccination: A cross-sectional study in Kazakhstan.
    Womens Health (Lond). 2023;19:17455057231172355.
    PubMed    
    Abstract available

  188. ZUO Y, Xiao H, Lv D, Huang M, et al
    Infection pattern and immunological characteristics of Epstein-Barr virus latent infection in cervical squamous cell carcinoma.
    J Med Virol. 2023;95:e28717.
    PubMed    
    Abstract available

  189. LI S, Liu J, Zhang W, Lu H, et al
    T1 mapping and multimodel diffusion-weighted imaging in the assessment of cervical cancer: a preliminary study.
    Br J Radiol. 2023 May 15:20220952. doi: 10.1259/bjr.20220952.
    PubMed    
    Abstract available

  190. YU Y, Liu Y, Li Y, Yang X, et al
    Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer.
    Cancer Cell Int. 2023;23:92.
    PubMed    
    Abstract available

  191. ESTENSON L, Kim N, Jacobson M
    Do age-based discontinuation recommendations influence cervical cancer screening rates? Evidence from the United States' Behavioral Risk Factor Surveillance System, 2016 and 2018.
    Prev Med. 2023;172:107543.
    PubMed    
    Abstract available

  192. SHARMA K, Machalek DA, Toh ZQ, Amenu D, et al
    No woman left behind: achieving cervical cancer elimination among women living with HIV.
    Lancet HIV. 2023 May 11:S2352-3018(23)00082.
    PubMed    
    Abstract available

  193. PRETSCH PK, Spees LP, Brewer NT, Hudgens MG, et al
    Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial.
    Lancet Public Health. 2023 May 11:S2468-2667(23)00076.
    PubMed    
    Abstract available

  194. WANG R, Coleman JS
    The HPV self-collection paradox: boosting cervical cancer screening, struggling with follow-up care.
    Lancet Public Health. 2023 May 11:S2468-2667(23)00094.
    PubMed    


  195. WANG L, Liu P, Duan H, Li P, et al
    Evaluation of individualized para-tumor resection of cervical cancer patients based on three-dimensional reconstruction.
    Front Surg. 2023;10:1174490.
    PubMed    
    Abstract available

  196. BRITTO AMA, Siqueira JD, Curty G, Goes LR, et al
    Microbiome analysis of Brazilian women cervix reveals specific bacterial abundance correlation to RIG-like receptor gene expression.
    Front Immunol. 2023;14:1147950.
    PubMed    
    Abstract available

  197. YU L, Lanqing G, Huang Z, Xin X, et al
    T cell immunotherapy for cervical cancer: challenges and opportunities.
    Front Immunol. 2023;14:1105265.
    PubMed    
    Abstract available

  198. NASIRI-AGHDAM M, Garcia-Chagollan M, Pereira-Suarez AL, Aguilar-Lemarroy A, et al
    Splicing Characterization and Isoform Switch Events in Human Keratinocytes Carrying Oncogenes from High-Risk HPV-16 and Low-Risk HPV-84.
    Int J Mol Sci. 2023;24:8347.
    PubMed    
    Abstract available

  199. POPIEL-KOPACZYK A, Piotrowska A, Sputa-Grzegrzolka P, Smolarz B, et al
    The Immunohistochemical Expression of Epithelial-Mesenchymal Transition Markers in Precancerous Lesions and Cervical Cancer.
    Int J Mol Sci. 2023;24:8063.
    PubMed    
    Abstract available

  200. HAN X, Fang F, Cui W, Liu Y, et al
    Effect of Ethanol-Induced Methyl Donors Consumption on the State of Hypomethylation in Cervical Cancer.
    Int J Mol Sci. 2023;24:7729.
    PubMed    
    Abstract available

  201. ASARE M, Elizondo A, Dwumfour-Poku M, Mena C, et al
    Intervention to Increase Cervical Cancer Screening Behavior among Medically Underserved Women: Effectiveness of 3R Communication Model.
    Healthcare (Basel). 2023;11:1323.
    PubMed    
    Abstract available

  202. BRYAN SJ, Lee J, Gunu R, Jones A, et al
    Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study.
    Cancers (Basel). 2023;15:2590.
    PubMed    
    Abstract available

  203. KUTLE I, Polten R, Hachenberg J, Klapdor R, et al
    Tumor Organoid and Spheroid Models for Cervical Cancer.
    Cancers (Basel). 2023;15:2518.
    PubMed    
    Abstract available

  204. XIANG X, Zhang Y, Hua K, Ding J, et al
    Impacts of ovarian preservation on the prognosis of neuroendocrine cervical carcinoma: a retrospective analysis based on machine learning.
    World J Surg Oncol. 2023;21:146.
    PubMed    
    Abstract available

  205. HOSSEINI Z, Seyrafi N, Homayuni A, Mouseli A, et al
    Predicting cervical cancer screening behavior among women in southern Iran: a cross-sectional study with PEN-3 model.
    BMC Womens Health. 2023;23:260.
    PubMed    
    Abstract available

  206. QI K, Lin G, Liu H, Zhang X, et al
    Comparison between radical surgery and chemoradiotherapy in patients with cervical esophageal cancer: a propensity score matched analysis.
    BMC Surg. 2023;23:119.
    PubMed    
    Abstract available

  207. DROUIN E, Classe JM, Hautecoeur P
    125 years of the Wertheim operation. What next?
    J Med Life. 2023;16:341-343.
    PubMed    
    Abstract available

  208. WENG G, Wang B, Ye Y, Zhang Q, et al
    Application of Microscopic Highly Hydrophilic Silica-Based Nanocomposites with High Surface Exposure in the Efficient Identification of Intact N-Glycopeptides.
    Anal Chem. 2023;95:7735-7742.
    PubMed    
    Abstract available

  209. RUAN Y, Li H, Liu M, Cao G, et al
    A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine.
    Cancer Epidemiol. 2023;84:102372.
    PubMed    
    Abstract available

  210. LI N, Cheng C, Liang R, Zhu Q, et al
    Epidemiological analysis of HPV in Sichuan during 2014-2021.
    Cancer Epidemiol. 2023;84:102360.
    PubMed    
    Abstract available

  211. GOPALANI SV, Soman A, Shapiro JA, Miller JW, et al
    Breast, cervical, and colorectal cancer screening test use in the US territories of Guam, Puerto Rico, and the US Virgin Islands.
    Cancer Epidemiol. 2023;84:102371.
    PubMed    
    Abstract available

  212. PERKINS RB, Smith DL, Jeronimo J, Campos NG, et al
    Use of risk-based cervical screening programs in resource-limited settings.
    Cancer Epidemiol. 2023;84:102369.
    PubMed    
    Abstract available

  213. MONDAL K, Muskaan, Mourya A, Choudhary S, et al
    Plan quality score to evaluate the dwell time deviation restricted inverse planning by simulated annealing and graphically optimized treatment plans for template based interstitial brachytherapy.
    Cancer Radiother. 2023;27:196-205.
    PubMed    
    Abstract available

  214. CONLEY MJ, Epifano I, Kirk A, Stevenson A, et al
    Microwave hyperthermia represses human papillomavirus oncoprotein activity and induces cell death due to cell stress in 3D tissue models of anogenital precancers and cancers.
    EBioMedicine. 2023;91:104577.
    PubMed    
    Abstract available

  215. MONIST M, Lewkowicz D, Pietak P, Pilewska-Kozak A, et al
    Synchronously occurring endometrioid carcinomas of the uterine corpus and uterine cervix preceded by different precancerous lesions: A case study and a literature review.
    Pathol Res Pract. 2023;245:154452.
    PubMed    
    Abstract available

  216. AYNAUD O, Huynh B, Bergeron C
    High-grade and low-grade HPV-induced urethral lesions treated by CO(2) laser under colposcopy.
    Sex Transm Infect. 2023 Mar 29:sextrans-2022-055503.
    PubMed    
    Abstract available

  217. ISHII K, Tabuchi T, Iso H
    Trends in socioeconomic inequalities in cervical, breast, and colorectal cancer screening participation among women in Japan, 2010-2019.
    Cancer Epidemiol. 2023;84:102353.
    PubMed    
    Abstract available

  218. JIANG YF, Jiang Y, Bi JH, Zhang Y, et al
    Relative survival analysis of gynecological cancers in an urban district of Shanghai during 2002-2013.
    Cancer Epidemiol. 2023;84:102355.
    PubMed    
    Abstract available

  219. WEYL A, Sanson C, Roumiguie M, Chaynes P, et al
    The lymphatic system of the uterine cervix: towards a more precise definition of the drainage routes.
    Surg Radiol Anat. 2023;45:653-659.
    PubMed    
    Abstract available

  220. WANG A, Zhou D, Krawczyk E, Li T, et al
    Overexpression of the telomerase holoenzyme induces EMT and tumorigenesis of HPV-immortalized keratinocytes.
    J Med Virol. 2023;95:e28681.
    PubMed    
    Abstract available

  221. ZENG C, Wu JK, Lu X
    Clinicopathological features and immunophenotype of Silva pattern system in endocervical adenocarcinoma.
    Int J Exp Pathol. 2023;104:140-150.
    PubMed    
    Abstract available

  222. MCKENZIE KA, Mahnken JD
    Simulating and estimating agreement in the presence of multiple raters and covariates.
    Stat Med. 2023;42:1687-1698.
    PubMed    
    Abstract available

  223. SHARMA AE, Hodgson AJ, Howitt BE, Olkhov-Mitsel E, et al
    Molecular correlates of invasion pattern in HPV-associated endocervical adenocarcinoma: emergence of two distinct risk-stratified tiers.
    Histopathology. 2023;82:1067-1078.
    PubMed    
    Abstract available

  224. METZ CK, Skof AS, Sehouli J, Siedentopf JP, et al
    Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study.
    Arch Gynecol Obstet. 2023;308:207-218.
    PubMed    
    Abstract available

  225. MONTI E, Libutti G, Di Loreto E, Boero V, et al
    High-grade vaginal intraepithelial neoplasia and recurrence risk: analysis of an Italian regional referral center series.
    Arch Gynecol Obstet. 2023;308:201-206.
    PubMed    
    Abstract available

  226. KOC S, Yuksel D, Kinay T, Burkankulu D, et al
    Histological results of HPV genotyping from a colposcopy center.
    Arch Gynecol Obstet. 2023;308:193-200.
    PubMed    
    Abstract available

  227. TATAR B
    Incorporating HPV 33 and cytology into HPV 16/18 screening may be feasible. A cross-sectional study.
    Arch Gynecol Obstet. 2023;308:183-191.
    PubMed    
    Abstract available

  228. ZHANG H, Zhang S
    Prevalence and genotype distribution of human papillomavirus infection among female outpatients in Northeast China: a population-based survey of 110,927 women.
    Arch Gynecol Obstet. 2023;308:35-41.
    PubMed    
    Abstract available

  229. WARD M, Beltran T, Corbo A, Sevilla M, et al
    Knowledge and Attitudes Regarding Human Papillomavirus Among Active Duty Service Members at a Large Military Base.
    Mil Med. 2023;188.
    PubMed    
    Abstract available

  230. DAVIDSON T, Yakobi Y, Nayruz K, Levin G, et al
    Early prediction of urinary retention following radical hysterectomy by 18F-FDG PET/CT imaging.
    Minerva Obstet Gynecol. 2023;75:243-250.
    PubMed    
    Abstract available

  231. CHENG H, Li Y, Cheng J, Zhang Y, et al
    Study on the effect and mechanisms of piperine against cervical cancer based on network pharmacology and experimental validation.
    Biotechnol Genet Eng Rev. 2023 May 26:1-24. doi: 10.1080/02648725.2023.2217611.
    PubMed    
    Abstract available

  232. LI Y, Gao X, Huang Y, Zhu X, et al
    Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications.
    Front Oncol. 2023;13:1114042.
    PubMed    
    Abstract available

  233. DABI Y, Favier A, Razakamanantsoa L, Suisse S, et al
    Value of non-coding RNAs to assess lymph node status in cervical cancer.
    Front Oncol. 2023;13:1144672.
    PubMed    
    Abstract available

  234. XIA X, Wang Y, Shao Y, Xu J, et al
    Marine Sulfated Polysaccharide PMGS Synergizes with Paclitaxel in Inhibiting Cervical Cancer In Vitro.
    Mar Drugs. 2023;21:259.
    PubMed    
    Abstract available

  235. FAYE MD, Petruccelli Araujo M, Wissing MD, Alrabiah K, et al
    Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer-A Single Institution Retrospective Study.
    Curr Oncol. 2023;30:4966-4978.
    PubMed    
    Abstract available

  236. PARKER SL, Deshmukh AA, Chen B, Lairson DR, et al
    Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey.
    Elife. 2023;12:e84664.
    PubMed    
    Abstract available

  237. UEZONO H, Tsujino K, Miyazaki S, Marudai M, et al
    Reduced Risk of Lymphedema With Intensity-modulated Radiation Therapy Compared With 3-dimensional Conformal Radiation Therapy in Patients With Cervical Cancer Who Received Postoperative Pelvic Radiation Therapy.
    Am J Clin Oncol. 2023 May 26. doi: 10.1097/COC.0000000000001018.
    PubMed    
    Abstract available

  238. GALINDO JF, Formigari GM, Zeferino LC, Carvalho CF, et al
    Social determinants influencing cervical cancer diagnosis: an ecological study.
    Int J Equity Health. 2023;22:102.
    PubMed    
    Abstract available

  239. SHEN TT, Long CY, Wu MP
    Favorable cervical cancer mortality-to-incidence ratios of countries with good human development index rankings and high health expenditures.
    BMC Womens Health. 2023;23:284.
    PubMed    
    Abstract available

  240. PAYNE DA, Terraschke A, Yoshida K, Osasah VA, et al
    Aotearoa New Zealand Deaf women's perspectives on breast and cervical cancer screening.
    N Z Med J. 2023;136:40-48.
    PubMed    
    Abstract available

  241. LI X, Liu L, He J, Yan J, et al
    Analysis of the effectiveness of the application of pelvic floor rehabilitation exercise and the factors influencing its self-efficacy in postoperative patients with cervical cancer.
    Front Oncol. 2023;13:1118794.
    PubMed    
    Abstract available


  242. Statement of Retraction: Long non-coding RNA SNHG4 promotes cervical cancer progression through regulating c-Met via targeting miR-148a-3p.
    Cell Cycle. 2023 May 25:1. doi: 10.1080/15384101.2023.2211864.
    PubMed    


  243. MATSUOKA N, Katsuno T, Tagami G, Ishizuka K, et al
    Granulocyte-colony stimulating factor producing cervical cancer with elevated levels of parathyroid hormone-related protein: a case report and literature review.
    CEN Case Rep. 2023 May 25. doi: 10.1007/s13730-023-00788.
    PubMed    
    Abstract available

  244. MAN I, Georges D, Bonjour M, Baussano I, et al
    Approximating missing epidemiological data for cervical cancer through Footprinting: A case study in India.
    Elife. 2023;12:e81752.
    PubMed    
    Abstract available

  245. HAQSHENAS G, Molano M, Phillips S, Balgovind P, et al
    Evaluation of Seegene Anyplex II Performance for Detection of Human Papillomavirus Genotypes in Formalin-Fixed, Paraffin-Embedded Cervical Cancer Specimens.
    Arch Pathol Lab Med. 2023 May 23. doi: 10.5858/arpa.2022-0317.
    PubMed    
    Abstract available

  246. JEUDIN PP, Sanchez-Covarrubias AP, Thiele AR, Reis IM, et al
    Differences in Cervical Cancer Outcomes by Caribbean Nativity in Black and White Women in Florida.
    Cancer Control. 2023;30:10732748231176642.
    PubMed    
    Abstract available

  247. ADEYEMI SA, Az-Zamakhshariy Z, Choonara YE
    In Vitro Prototyping of a Nano-Organogel for Thermo-Sonic Intra-Cervical Delivery of 5-Fluorouracil-Loaded Solid Lipid Nanoparticles for Cervical Cancer.
    AAPS PharmSciTech. 2023;24:123.
    PubMed    
    Abstract available

  248. CEGLA P, Hofheinz F, Burchardt E, Czepczynski R, et al
    Asphericity derived from [(18)F]FDG PET as a new prognostic parameter in cervical cancer patients.
    Sci Rep. 2023;13:8423.
    PubMed    
    Abstract available

  249. ALBERTON DL, Salcedo MP, Zen RP, Ferreira CF, et al
    Conservative Treatment of Stage IA1 Cervical Carcinoma Without Lymphovascular Space Invasion: A 20-year Retrospective Study in Brazil.
    Rev Bras Ginecol Obstet. 2023;45:201-206.
    PubMed    
    Abstract available

  250. ZHANG T, Zhuang L, Muaibati M, Wang D, et al
    Identification of cervical cancer stem cells using single-cell transcriptomes of normal cervix, cervical premalignant lesions, and cervical cancer.
    EBioMedicine. 2023;92:104612.
    PubMed    
    Abstract available

  251. DELGADO-WALDO I, Contreras-Romero C, Salazar-Aguilar S, Pessoa J, et al
    A triple-drug combination induces apoptosis in cervical cancer-derived cell lines.
    Front Oncol. 2023;13:1106667.
    PubMed    
    Abstract available

  252. ADLER D, Bonham A, Chamberlin S, Fiscella K, et al
    A scalable approach to determine cervical cancer screening needs among emergency department patients in the United States.
    Prev Med Rep. 2023;33:102221.
    PubMed    
    Abstract available

  253. BENDAHHOU K, Serhier Z, Diouny S, Ouadii K, et al
    Women's Knowledge and Attitudes Towards Cervical Cancer Screening in Morocco.
    Cureus. 2023;15:e37989.
    PubMed    
    Abstract available

  254. CHEN Y, Huang B, Zheng J, He F, et al
    Prediction study of prognostic nutrition index on the quality of life of patients with cervical cancer undergoing radiotherapy and chemotherapy.
    PeerJ. 2023;11:e15442.
    PubMed    
    Abstract available

  255. ANDRIKOS D, Andrikos A, Naem A, Ebertz O, et al
    Advanced cervical stump cancer after laparoscopic subtotal hysterectomy: a case report of imaging, laparoscopic staging and treatment approach.
    BMC Womens Health. 2023;23:281.
    PubMed    
    Abstract available

  256. KIM J, Jo H, Ha MC, Kim H, et al
    Elevated risk of cervical cancer in elderly women with incident ulcerative colitis in South Korea.
    Sci Rep. 2023;13:8323.
    PubMed    
    Abstract available

  257. DEGIFE EA, Oliveira CR, Znamierowski E, Meyer JP, et al
    Uptake of Cervical Cancer Screening Among Female Patients Using a Mobile Medical Clinic.
    Am J Prev Med. 2023 May 21:S0749-3797(23)00238.
    PubMed    
    Abstract available

  258. BERGERON C, Orth G
    [The prevention of cervical cancer].
    Med Sci (Paris). 2023;39:423-428.
    PubMed    
    Abstract available


  259. Retraction statement: Dai, Y., Xie, F. and Chen, Y. (2020), Reduced levels of miR-485-5p in HPV-infected cervical cancer promote cell proliferation and enhance invasion ability. FEBS Open Bio, 10: 1348-1361.
    FEBS Open Bio. 2023 May 23. doi: 10.1002/2211-5463.13622.
    PubMed    


  260. TANZI E, Bianchi S, Fappani C, Gori M, et al
    Detection of human papillomavirus in fresh and dried urine through an automated system for cervical cancer screening in low- and middle-income countries.
    J Med Virol. 2023;95:e28802.
    PubMed    
    Abstract available

  261. ZHANG CY, Zhang L, Wang ZM, Ren DH, et al
    The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers.
    J Obstet Gynaecol. 2023;43:2213764.
    PubMed    
    Abstract available

  262. SHAFIQ MH, Mansoor M, Arshad A, Mansoor S, et al
    Frequency of human papilloma virus (HPV) vaccination among female health care providers and reasons for non-immunization at a public sector hospital.
    J Pak Med Assoc. 2023;73:1159-1163.
    PubMed    
    Abstract available

  263. FENG T, Shou HF, Yuan SH, Tang HR, et al
    [Treatment and prognosis analysis of 488 patients with FIGO 2018 stage â…¢c squamous cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2023;58:359-367.
    PubMed    
    Abstract available

  264. FEYISA JD, Woldegeorgis MA, Zingeta GT, Abegaz KH, et al
    Cervical Cancer Progression in Patients Waiting for Radiotherapy Treatment at a Referral Center in Ethiopia: A Longitudinal Study.
    JCO Glob Oncol. 2023;9:e2200435.
    PubMed    
    Abstract available

  265. LEE SH, Abdul Rahim N, Ong SK, Abdul Rahman H, et al
    Survival of cervical cancer patients in Brunei Darussalam: 2002-2017.
    Heliyon. 2023;9:e16080.
    PubMed    
    Abstract available

  266. YE BQ, Zhao CZ, Sun PF
    Variations and effects of bladder and rectal volume following uniform preparation procedure in cervical cancer: Five fractions of 6 Gy.
    J Contemp Brachytherapy. 2023;15:123-129.
    PubMed    
    Abstract available

  267. XIE H, Wang J, Chen Y, Tu Y, et al
    Automatic reconstruction of interstitial needles using CT images in post-operative cervical cancer brachytherapy based on deep learning.
    J Contemp Brachytherapy. 2023;15:134-140.
    PubMed    
    Abstract available

  268. XU Y, Sun Y, Song X, Ren J, et al
    The mechanisms and diagnostic potential of lncRNAs, miRNAs, and their related signaling pathways in cervical cancer.
    Front Cell Dev Biol. 2023;11:1170059.
    PubMed    
    Abstract available

  269. DENG Y, Jiang H, Wu D
    Association of MicroRNA-10b Expression and P16 with Pathological Features in Various Stages of Cervical Precancerous Lesions.
    Cell Mol Biol (Noisy-le-grand). 2023;69:109-113.
    PubMed    
    Abstract available

  270. ROCKSON L, Btoush R
    Cervical Cancer Screening Among Older Garifuna Women Residing in New York City.
    J Racial Ethn Health Disparities. 2023 May 22. doi: 10.1007/s40615-023-01635.
    PubMed    
    Abstract available

  271. ROSARIO A, Sousa A, Varandas T, Marinho-Dias J, et al
    Impact of cervicovaginal microbiome on the risk of cervical abnormalities development.
    J Med Virol. 2023;95:e28762.
    PubMed    
    Abstract available

  272. ZENG X, Wang Y, Liu B, Rao X, et al
    Multi-omics data reveals novel impacts of human papillomavirus integration on the epigenomic and transcriptomic signatures of cervical tumorigenesis.
    J Med Virol. 2023;95:e28789.
    PubMed    
    Abstract available

  273. TAMURA D, Sako W, Watanabe R, Shitara A, et al
    Distribution of cervical intraepithelial neoplasia is closely associated with HPV status and uterine position.
    J Med Virol. 2023;95:e28777.
    PubMed    
    Abstract available

  274. MACIOS A, Komerska K, Nowakowski A
    Reasons for truly negative cytology reports preceding the diagnoses of invasive cervical cancer-Results of a false-negative cytology audit in Polish Cervical Cancer Screening Programme.
    Cancer Med. 2023 May 22. doi: 10.1002/cam4.6024.
    PubMed    
    Abstract available

  275. HARPER DM, Anderson RJ, Baker E, Yu TM, et al
    Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening.
    Cancer Prev Res (Phila). 2023 May 19:CAPR-22-0455.
    PubMed    
    Abstract available

  276. ADDISU D, Gebeyehu NA, Belachew YY
    Knowledge, attitude, and uptake of human papillomavirus vaccine among adolescent schoolgirls in Ethiopia: a systematic review and meta-analysis.
    BMC Womens Health. 2023;23:279.
    PubMed    
    Abstract available

  277. GROVER S, Seckar T, Gao L, Bhatia R, et al
    Characterization of HPV subtypes in invasive cervical cancer in Botswana patients using a pan-pathogen microarray technology.
    Tumour Virus Res. 2023 May 18:200262. doi: 10.1016/j.tvr.2023.200262.
    PubMed    
    Abstract available

  278. ESSOH TA, Adeyanju GC, Adamu AA, Tall H, et al
    Exploring the factors contributing to low vaccination uptake for nationally recommended routine childhood and adolescent vaccines in Kenya.
    BMC Public Health. 2023;23:912.
    PubMed    
    Abstract available

  279. BROSNAN B, Skarga-Bandurova I, Biloborodova T, Skarha-Bandurov I, et al
    An Integrated Approach to Automated Diagnosis of Cervical Intraepithelial Neoplasia in Digital Histology Images.
    Stud Health Technol Inform. 2023;302:615-616.
    PubMed    
    Abstract available

  280. ROHR THOMSEN C, Leonhard AK, Strandbo Schmidt Jensen M, Bor P, et al
    Quantitative strain elastography of the uterine cervix assessed by the GE Voluson E10 system in combination with a force-measuring device.
    J Matern Fetal Neonatal Med. 2023;36:2213797.
    PubMed    
    Abstract available

  281. SEEFOO-JARQUIN P, Sosa-Jurado F, Maycotte-Gonzalez P
    [Epidemiological Panorama of Cervical Dysplasia in a First-Level Care Unit].
    Rev Med Inst Mex Seguro Soc. 2023;61:155-162.
    PubMed    
    Abstract available

  282. CHEUNG TH, Cheng SSY, Hsu D, Wing-Lei Wong Q, et al
    Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong.
    Hum Vaccin Immunother. 2023;19:2184605.
    PubMed    
    Abstract available

  283. ZHANG L, Mosquera I, Lucas E, Rol ML, et al
    CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs.
    Nat Med. 2023;29:1135-1145.
    PubMed    
    Abstract available

  284. VASSILAKOS P, Clarke H, Murtas M, Stegmuller T, et al
    Telecytologic diagnosis of cervical smears for triage of self-sampled human papillomavirus-positive women in a resource-limited setting: concept development before implementation.
    J Am Soc Cytopathol. 2023;12:170-180.
    PubMed    
    Abstract available

  285. TIAN R, Huang Z, Li L, Yuan J, et al
    HPV integration generates a cellular super-enhancer which functions as ecDNA to regulate genome-wide transcription.
    Nucleic Acids Res. 2023;51:4237-4251.
    PubMed    
    Abstract available

  286. CHIDAMBARAM S, Chang SH, Sandulache VC, Mazul AL, et al
    Human Papillomavirus Vaccination Prevalence and Disproportionate Cancer Burden Among US Veterans.
    JAMA Oncol. 2023;9:712-714.
    PubMed    


  287. KARAASLAN S, Dilcher TL, Abdelsayed M, Goyal A, et al
    Significant outcomes associated with high-risk human papillomavirus negative Papanicolaou tests.
    J Am Soc Cytopathol. 2023;12:189-196.
    PubMed    
    Abstract available

  288. JOHNSON G, Miquel-Chambers C, Blas Y, Lowery S, et al
    Women's Health Maintenance Efforts at a Student-Run Free Clinic in South Florida Exceeded National Trends During the COVID-19 Pandemic.
    J Community Health. 2023;48:501-507.
    PubMed    
    Abstract available

  289. VIJAYALAKSHMI K, Goei AHY
    Improved population coverage of the human papillomavirus vaccine after implementation of a school-based vaccination programme: the Singapore experience.
    Singapore Med J. 2023;64:294-301.
    PubMed    
    Abstract available

  290. SKORSTENGAARD M, Viborg PH, Telen Andersen AB, Andersen B, et al
    A cervical screening initiative for elderly women in Denmark.
    Acta Obstet Gynecol Scand. 2023;102:791-800.
    PubMed    
    Abstract available

  291. SPENCER JC, Noel L, Shokar NK, Pignone MP, et al
    Understanding the role of access in Hispanic cancer screening disparities.
    Cancer. 2023;129:1569-1578.
    PubMed    
    Abstract available

  292. KIM SI, Nam SH, Hwangbo S, Kim Y, et al
    Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R).
    Gynecol Oncol. 2023;173:88-97.
    PubMed    
    Abstract available

  293. FUREY KB, Anderson ZS, Kuznicki ML, Klar M, et al
    Increasing trends of cervical conization with lymph node evaluation for fertility-sparing surgery in early cervical cancer.
    Gynecol Oncol. 2023;173:122-129.
    PubMed    
    Abstract available

  294. VERGOTE I, Van Nieuwenhuysen E, Casado A, Laenen A, et al
    Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer.
    Gynecol Oncol. 2023;174:80-88.
    PubMed    
    Abstract available

  295. ROBOVA H, Rob L, Halaska MJ, Drozenova J, et al
    Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: Pregnancy outcomes.
    Gynecol Oncol. 2023;174:76-79.
    PubMed    
    Abstract available

  296. DI DONATO V, Bogani G, Casarin J, Ghezzi F, et al
    Ten-year outcomes following laparoscopic and open abdominal radical hysterectomy for "low-risk" early-stage cervical cancer: A propensity-score based analysis.
    Gynecol Oncol. 2023;174:49-54.
    PubMed    
    Abstract available

  297. PIEDIMONTE S, Helpman L, Pond G, Nelson G, et al
    Surgical margin status in relation to surgical approach in the management of early-stage cervical Cancer: A Canadian cervical Cancer collaborative (4C) study.
    Gynecol Oncol. 2023;174:21-27.
    PubMed    
    Abstract available

  298. HAN L, Chen Y, Zheng A, Chen H, et al
    Effect of preoperative cervical conization before hysterectomy on survival and recurrence of patients with cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2023;174:167-174.
    PubMed    
    Abstract available

  299. KIM NR, Kim SI, Suh DH, Kim HS, et al
    Survival outcomes of laparoscopic versus open radical hysterectomy in early cervical cancer with incidentally identified high-risk factors.
    Gynecol Oncol. 2023;174:224-230.
    PubMed    
    Abstract available

  300. CUZICK J, Adcock R, Kinney W, Castle PE, et al
    Impact of HPV testing in Opportunistic Cervical Screening: Support for Primary HPV Screening in the United States.
    Int J Cancer. 2023 Mar 22. doi: 10.1002/ijc.34519.
    PubMed    
    Abstract available

  301. REBOLJ M, Sargent A, Njor SH, Cuschieri K, et al
    Widening the offer of human papillomavirus self-sampling to all women eligible for cervical screening: Make haste slowly.
    Int J Cancer. 2023;153:8-19.
    PubMed    
    Abstract available

  302. WEVER BMM, van den Helder R, van Splunter AP, van Gent MDJM, et al
    DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self-samples, and cervical scrapes.
    Int J Cancer. 2023 Mar 13. doi: 10.1002/ijc.34504.
    PubMed    
    Abstract available

  303. DONG L, Nygard M, Stoer NC, Klungsoyr O, et al
    Real-World Effectiveness of Hpv Vaccination Against Cervical Neoplasia Among Birth Cohorts Ineligible for Routine Vaccination.
    Int J Cancer. 2023 Mar 3. doi: 10.1002/ijc.34489.
    PubMed    
    Abstract available

  304. CIBULA D, Raspollini MR, Planchamp F, Centeno C, et al
    ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
    Int J Gynecol Cancer. 2023;33:649-666.
    PubMed    
    Abstract available

  305. ISHIKAWA M, Shibata T, Kataoka T, Takekuma M, et al
    Final analysis of a randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinom
    Int J Gynecol Cancer. 2023;33:692-700.
    PubMed    
    Abstract available

  306. PELEG HASSON S, Felder S, Helpman L, Taylor A, et al
    Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix.
    Int J Gynecol Cancer. 2023;33:683-691.
    PubMed    
    Abstract available

  307. CUSCHIERI K, Fellner MD, Arroyo Muhr LS, Padalko E, et al
    Quality assurance in human papillomavirus testing for primary cervical screening.
    Int J Gynecol Cancer. 2023;33:802-811.
    PubMed    
    Abstract available

  308. LEVYTSKA K, Pena SR, Brown J, Yu Z, et al
    Opioid and benzodiazepine use in gynecologic oncology patients.
    Int J Gynecol Cancer. 2023;33:786-791.
    PubMed    
    Abstract available

  309. ZHANG X, Wang Y, Lv X, Wang F, et al
    Intratumoral injection of oncolytic virus (H101) in combination with concurrent chemoradiotherapy for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2023 May 19:ijgc-2022-003914.
    PubMed    
    Abstract available

  310. VIVEROS-CARRENO D, Vieira-Serna S, Grillo-Ardila CF, Rodriguez J, et al
    Definitive pelvic radiotherapy for patients with newly diagnosed stage IVB cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2023 May 16:ijgc-2023-004465.
    PubMed    
    Abstract available

  311. BUDA A, Fanfani F
    The patterns of growth of cervical cancer: a challenge to personalized radical surgery.
    Int J Gynecol Cancer. 2023 Apr 25:ijgc-2023-004556.
    PubMed    


  312. LIN LL, Msadabwe SC, Chiao E
    Improving Access to Radiation Therapy Globally To Meet World Health Organization Goals To Eliminate Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2023;116:459-462.
    PubMed    


  313. LIN LL, Ndlovu N, Lowenstein J, Wirth M, et al
    Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan Africa.
    Int J Radiat Oncol Biol Phys. 2023;116:439-447.
    PubMed    
    Abstract available

  314. NDIAYE M, Diop G, Derbois C, Spadoni JL, et al
    Gene expression profiling of peripheral blood mononuclear cells from women with cervical lesions reveals new markers of cancer.
    Oncol Rep. 2023;49:118.
    PubMed    
    Abstract available

  315. LI M, Gao Z, Wang S, Zhao Y, et al
    miR‑27a‑3p upregulation by p65 facilitates cervical tumorigenesis by increasing TAB3 expression and is involved in the positive feedback loop of NF‑kappaB signaling.
    Oncol Rep. 2023;50:132.
    PubMed    
    Abstract available

  316. ZHANG HW, Zhong XM, Zhang ZH, Pang HW, et al
    Dose prediction of organs at risk in patients with cervical cancer receiving brachytherapy using needle insertion based on a neural network method.
    BMC Cancer. 2023;23:385.
    PubMed    
    Abstract available

  317. MATOVU JK, Wagner GJ, Juncker M, Namisango E, et al
    Mediators and moderators of the effect of the game changers for cervical cancer prevention intervention on cervical cancer screening among previously unscreened social network members in Uganda.
    BMC Cancer. 2023;23:428.
    PubMed    
    Abstract available

  318. YE Y, Li Z, Kang S, Yang Y, et al
    Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
    BMC Cancer. 2023;23:421.
    PubMed    
    Abstract available

  319. BOOTH BB, Tranberg M, Gustafson LW, Christiansen AG, et al
    Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged >/= 69 referred to colposcopy due to an HPV-positive screening test.
    BMC Cancer. 2023;23:405.
    PubMed    
    Abstract available

  320. BELAY AS, Asmare WN, Kassie A
    Cervical cancer screening utilization and its predictors among women in bench Sheko Zone, Southwest Ethiopia: using health belief model.
    BMC Cancer. 2023;23:472.
    PubMed    
    Abstract available

  321. LEONG E, Ong SK, Si-Ramlee KA, Naing L, et al
    Cancer incidence and mortality in Brunei Darussalam, 2011 to 2020.
    BMC Cancer. 2023;23:466.
    PubMed    
    Abstract available

  322. LIVESEY M, Rossouw SC, Blignaut R, Christoffels A, et al
    Transforming RNA-Seq gene expression to track cancer progression in the multi-stage early to advanced-stage cancer development.
    PLoS One. 2023;18:e0284458.
    PubMed    
    Abstract available


  323. Expression of Concern: Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis.
    PLoS One. 2023;18:e0285579.
    PubMed    


  324. HOLOPAINEN E, Lahtinen O, Kononen M, Anttila M, et al
    Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer.
    PLoS One. 2023;18:e0285786.
    PubMed    
    Abstract available

  325. OKAFOR IP, Kukoyi FO, Kanma-Okafor OJ, Izuka MO, et al
    Male involvement in female partners' screening for breast and cervical cancers in Southwest Nigeria.
    PLoS One. 2023;18:e0284141.
    PubMed    
    Abstract available

  326. MITI S, Shato T, Asante C, Baumann A, et al
    Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study.
    PLoS One. 2023;18:e0285031.
    PubMed    
    Abstract available

  327. KHOMPHAIBOONKIJ U, Sreamsukcharoenchai N, Pitakkarnkul S, Rittiluechai K, et al
    Knowledge of Thai women in cervical cancer etiology and screening.
    PLoS One. 2023;18:e0286011.
    PubMed    
    Abstract available

  328. KURITA Y, Meguro S, Tsuyama N, Kosugi I, et al
    Accurate deep learning model using semi-supervised learning and Noisy Student for cervical cancer screening in low magnification images.
    PLoS One. 2023;18:e0285996.
    PubMed    
    Abstract available

  329. PANERU B, Karmacharya A, Bharati A, Makaju S, et al
    Association between cancer stigma and cervical cancer screening uptake among women of Dhulikhel and Banepa, Nepal.
    PLoS One. 2023;18:e0285771.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;